Edition:
United Kingdom

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

51.57USD
9:00pm BST
Change (% chg)

$1.49 (+2.98%)
Prev Close
$50.08
Open
$50.10
Day's High
$51.71
Day's Low
$49.95
Volume
301,875
Avg. Vol
202,444
52-wk High
$60.98
52-wk Low
$35.86

About

Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). With a targeted mechanism of action, bempedoic acid, the... (more)

Overall

Beta: 1.95
Market Cap(Mil.): $1,348.03
Shares Outstanding(Mil.): 26.92
Dividend: --
Yield (%): --

Financials

  ESPR.OQ Industry Sector
P/E (TTM): -- 97.03 53.45
EPS (TTM): -2.74 -- --
ROI: -34.97 7.44 11.71
ROE: -35.10 7.90 16.35

Earnings vs. Estimates